BCR and leukemia: Experimental mouse models reveal that high-level expression of BCR::ABL alone is insufficient to induce leukemia, whereas co-expression with Setbp1, Hoxa10 or Hoxa9 produces aggressive leukemia within 3 weeks (11, 12).